MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Update Il y a 3 ans
Reference: NCT00207103

Woman and Man


This is a Phase I dose escalation study to determine the safety, pharmacokinetics and pharmacodynamics of BMS-582664 in patients with advanced or metastatic solid tumors.

Inclusion criteria

  • Tumors ,Neoplasm Metastasis